Profil
Philip A.
Band is the founder.
He founded CytoDel LLC in 2012 and currently holds the title of Chief Executive Officer & Director.
In addition to his founding position, Dr. Band also held the position of Vice President-Research at Biomatrix, Inc.
Aktive Positionen von Philip A. Band
| Unternehmen | Position | Beginn |
|---|---|---|
CytoDel LLC
 CytoDel LLC BiotechnologyHealth Technology CytoDel LLC is engaged in biotechnology services. Its products include Ctyo-111, first botulism antidote and Cyto-012, musculoskeletal and aesthetic medicine. The company was founded by Philip A. Band, Konstantin Ichtchenko and Edwin Vazquez Cintron in 2012 and is headquartered in New York City, NY. | Gründer | 01.01.2012 |
Ehemalige bekannte Positionen von Philip A. Band
| Unternehmen | Position | Ende |
|---|---|---|
Biomatrix, Inc.
 Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Biomatrix, Inc. develops, manufactures, markets and sells a series of proprietary viscoelastic products called 'hylans'. Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The company was founded by Endre A. Balazs and Janet L. Denlinger in 1981 and is headquartered in Ridgefield, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 11.05.2011 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Biomatrix, Inc.
Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Biomatrix, Inc. develops, manufactures, markets and sells a series of proprietary viscoelastic products called 'hylans'. Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The company was founded by Endre A. Balazs and Janet L. Denlinger in 1981 and is headquartered in Ridgefield, NJ. | Health Technology |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology CytoDel LLC is engaged in biotechnology services. Its products include Ctyo-111, first botulism antidote and Cyto-012, musculoskeletal and aesthetic medicine. The company was founded by Philip A. Band, Konstantin Ichtchenko and Edwin Vazquez Cintron in 2012 and is headquartered in New York City, NY. | Health Technology |
